| 0 |
Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] |
5 |
0.0083 |
| 1 |
Histone Deacetylase Inhibitor [EPC] |
1 |
0.0003 |
| 2 |
Carbonic Anhydrase Inhibitor [EPC] |
3 |
0.0001 |
| 3 |
Nuclear Export Inhibitor [EPC] |
1 |
0.0001 |
| 4 |
Sphingosine 1-phosphate Receptor Modulator [EPC] |
1 |
0.0001 |
| 5 |
Poly(ADP-Ribose) Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 6 |
Interleukin-12 Antagonist [EPC] |
4 |
0.0000 |
| 7 |
Interleukin-23 Antagonist [EPC] |
4 |
0.0000 |
| 8 |
Purine Antimetabolite [EPC] |
3 |
0.0000 |
| 9 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
5 |
0.0000 |
| 10 |
Alkylating Drug [EPC] |
6 |
0.0000 |
| 11 |
CD20-directed Cytolytic Antibody [EPC] |
7 |
0.0000 |
| 12 |
CTLA-4-directed Blocking Antibody [EPC] |
1 |
0.0000 |
| 13 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
2 |
0.0000 |
| 14 |
Kinase Inhibitor [EPC] |
9 |
0.0000 |
| 15 |
Interleukin-6 Receptor Antagonist [EPC] |
2 |
0.0000 |
| 16 |
beta-Adrenergic Blocker [EPC] |
4 |
0.0000 |
| 17 |
Retinoid [EPC] |
3 |
0.0000 |
| 18 |
Factor Xa Inhibitor [EPC] |
3 |
0.0000 |
| 19 |
Prostaglandin Analog [EPC] |
1 |
0.0000 |
| 20 |
Proton Pump Inhibitor [EPC] |
5 |
0.0000 |
| 21 |
Serotonin-3 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 22 |
Folate Analog Metabolic Inhibitor [EPC] |
3 |
0.0000 |
| 23 |
Tumor Necrosis Factor Blocker [EPC] |
4 |
0.0000 |
| 24 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
2 |
0.0000 |
| 25 |
Thalidomide Analog [EPC] |
2 |
0.0000 |
| 26 |
Platinum-based Drug [EPC] |
1 |
0.0000 |
| 27 |
Corticosteroid [EPC] |
4 |
0.0000 |
| 28 |
GLP-1 Receptor Agonist [EPC] |
1 |
0.0000 |
| 29 |
Insulin Analog [EPC] |
1 |
0.0000 |
| 30 |
Atypical Antipsychotic [EPC] |
1 |
0.0000 |
| 31 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
1 |
0.0000 |